Singapore markets closed
Straits Times Index
3,410.81 -29.07 (-0.85%) Nikkei
40,912.37 -1.28 (-0.00%) Hang Seng
17,799.61 -228.67 (-1.27%) FTSE 100
8,203.93 -37.33 (-0.45%) Bitcoin USD
57,142.34 +436.84 (+0.77%) CMC Crypto 200
1,189.03 -19.66 (-1.63%)
MRNA Aug 2024 136.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:34PM EDT. Market open.
| Previous close | 3.8600 |
| Open | N/A |
| Bid | 1.8100 |
| Ask | 3.0500 |
| Strike | 136.00 |
| Expiry date | 2024-08-09 |
| Day's range | 3.8600 - 3.8600 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
ZacksBiotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More
GSK and CureVac (CVAC) are in the spotlight following a restructuring of their vaccine agreement.
Barrons.comGSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
CureVac is also eligible for future royalties. CureVac shares jumped 12% in early trading Wednesday, while GSK’s American depositary receipt slipped 0.2%. Shares of Moderna a leading mRNA vaccine manufacturer, were up 0.9%.
ZacksModerna (MRNA) Secures BARDA Funding for Bird Flu Vaccine
Moderna (MRNA) expects this funding to help support the development of its mRNA-based pre-pandemic vaccine against the H5 influenza virus, which is responsible for causing avian influenza or bird flu.
© 2024 Yahoo. All rights reserved.